Halozyme Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Halozyme Therapeutics, Inc. (HALO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income444.09281.59202.13402.71129.09-72.24-80.33
Depreciation & Amortization88.6682.3649.643.003.284.122.39
Deferred Income Tax0.0034.5140.01-155.430.000.000.00
Stock Based Compensation43.3936.6224.4020.8217.200.000.00
Change in Working Capital-136.27-38.67-85.953.74-108.37-50.54-5.87
Change in Accounts Receivable-74.25-3.34-83.946.76-38.290.000.00
Change in Inventory-67.38-26.88-17.487.37-31.390.000.00
Change in Accounts Payable0.00-12.5524.541.17-41.210.000.00
Change in Other Working Capital5.364.10-9.06-11.562.520.000.00
Other Operating Activities39.2022.5839.09-136.72-0.5331.441.70
Net Cash from Operating Activities479.06388.57240.11299.4455.45-85.42-49.50
Investing Activities
Capital Expenditures-10.70-15.29-4.81-1.46-2.504.04-4.66
Acquisitions0.000.00-999.120.000.000.000.00
Purchases of Investments0.00-81.62490.92-404.8379.780.000.00
Sales/Maturities of Investments0.00-81.62490.92-404.8379.78-1.517.16
Other Investing Activities-252.030.000.000.000.000.000.00
Net Cash from Investing Activities-262.72-96.91-487.01-406.2978.35-5.552.49
Financing Activities
Debt Repayment0.00-13.48-447.45-369.06-19.56-108.36-77.52
Common Stock Issued0.007.8814.0512.5463.39-200.000.00
Common Stock Repurchased-250.00-402.38-200.00-350.06-150.120.000.00
Other Financing Activities31.147.88-76.22-0.420.000.000.00
Net Cash from Financing Activities-218.86-407.99362.3777.87-106.28153.22-63.80
Summary
Net Change in Cash-2.52-116.33115.48-28.9827.5262.24-110.80
Cash at Beginning of Period118.37234.70119.22148.20120.6858.44169.24
Cash at End of Period115.85286.08234.70119.22148.20120.6858.44
Free Cash Flow468.37373.28235.30297.9852.95-89.46-54.16
Supplemental Disclosures
Interest Paid10.5711.416.113.306.539.0316.89
Income Taxes Paid80.6231.7616.22-0.380.180.190.22